Third award from the Cancer Prevention and Research Institute of Texas caps a milestone year for the medtech company.
HOUSTON, Nov. 20, 2026 /PRNewswire-PRWeb/ -- Prana Surgical, a Houston-based medical technology company advancing surgical innovation, announced that the Cancer Prevention and Research Institute of Texas (CPRIT) has awarded the company a $12,321,572 Product Development Research grant. The award will fund the clinical validation and continued advancement of Prana's platform, supporting the company's next phase of US clinical validation of the FDA-cleared Prana System™.
The grant is one of 76 awards totaling more than $148 million approved today by CPRIT's Oversight Committee, the agency's largest funding action of the year. Prana is among 12 companies selected for product development funding to advance next-generation therapies, diagnostics, imaging technologies and surgical tools in Texas.
Chief Executive Officer Kristen Doyle said, "The awards funded today reflect the extraordinary innovation taking place across Texas. These investments support researchers, clinicians, entrepreneurs, and community leaders who are helping shape the future of cancer care and bringing new hope to Texans and Texas families."
In 2022, CPRIT granted the company $3 million to fund first-in-human studies of its technology, as well as a supplemental award in 2025 of $900K. That support led to the Prana System's first clinical procedures in Australia, performed by thoracic surgeon Dr. Gavin Wright in an early feasibility study that kicked off in November 2025. Months later Prana Surgical received U.S. Food and Drug Administration 510(k) clearance in April 2026.
"CPRIT believed in this technology when it was still being built at the bench, and that early support carried us through our first clinical procedures and FDA clearance," said Joanna Nathan, CEO and Co-Founder, Prana Surgical. "This award gives us the opportunity to build on that momentum and generate the clinical evidence needed to support broader adoption of our technology. This has been a banner year for Prana, marked by more major milestones than any other year in our company's history. I can't imagine a better way to close out the year and set the stage for our next chapter."
The Prana System is an innovative means to precisely remove tissue samples in a minimally invasive and highly targeted way. One application is in lung cancer, which remains the leading cause of cancer death in the United States. As screening expands, physicians are identifying more small, hard-to-reach lung nodules that present challenges for existing diagnostic and surgical techniques. Prana Surgical has developed a technology to address this challenge by giving surgeons a targeted approach to accessing and excising tissue. The FDA-cleared Prana System is being evaluated in CT-guided procedures, where surgeons use imaging to locate and access nodules for tissue excision.
The CPRIT grant will support further clinical evaluation and continued advancement of the Prana System. The award comes as Prana scales manufacturing, strengthens its supply chain, and expands commercial operations.
Please visit pranasurgical.com to learn more about Prana Surgical and the Prana System™.
About the Prana System™
The Prana System™ is an image-guided electrosurgical platform designed to enable minimally invasive approaches across procedures requiring precise targeting and tissue excision and conservation. The system integrates CT-guided targeting and excision into a single device to support tissue removal. Learn more at pranasurgical.com/prana-system.
About Prana Surgical
Prana Surgical is a Houston-based team of surgeons, engineers, and entrepreneurs developing image-guided surgical technologies to advance early intervention and improve treatment options for patients with various conditions, such as lung cancer. The company's mission is to redefine early lung-cancer intervention by enabling tissue-sparing, minimally invasive surgery that prioritizes patient quality of life. Learn more at pranasurgical.com.
About CPRIT
Created by the Texas Legislature and approved by Texas voters in 2007, the Cancer Prevention and Research Institute of Texas (CPRIT) is the state's premier agency for advancing cancer research, prevention, and innovation. In 2019, Texans overwhelmingly reaffirmed their commitment to CPRIT by approving an additional $3 billion in funding, bringing the state's total investment to $6 billion.
Since its inception, CPRIT has awarded more than $4 billion in grants to Texas research institutions and organizations through its academic research, prevention, and product development programs. CPRIT-funded investments have helped recruit 370 distinguished researchers to Texas, supported the establishment, expansion, or relocation of 90 companies, and delivered 13 million cancer prevention services across all 254 Texas counties.
Media Contact
Nubia DuVall Wilson, Prana Surgical, 1 6463570428, [email protected], pranasurgical.com
SOURCE Prana Surgical


Share this article